Squarepoint Ops LLC Sells 50,487 Shares of Sotera Health (NASDAQ:SHC)

Squarepoint Ops LLC reduced its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 80.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,970 shares of the company's stock after selling 50,487 shares during the quarter. Squarepoint Ops LLC's holdings in Sotera Health were worth $164,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Blue Trust Inc. grew its position in shares of Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after buying an additional 1,140 shares during the period. Quarry LP acquired a new stake in Sotera Health during the 4th quarter worth $28,000. Tower Research Capital LLC TRC raised its position in shares of Sotera Health by 37.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after acquiring an additional 1,640 shares during the last quarter. Sterling Capital Management LLC lifted its stake in shares of Sotera Health by 58.5% in the 4th quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock valued at $124,000 after purchasing an additional 3,331 shares during the period. Finally, PNC Financial Services Group Inc. lifted its stake in Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock valued at $127,000 after buying an additional 2,627 shares during the period. Institutional investors and hedge funds own 91.03% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on SHC shares. The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Barclays lowered their target price on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. Piper Sandler cut their price target on shares of Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Finally, Wall Street Zen downgraded Sotera Health from a "buy" rating to a "hold" rating in a research note on Saturday. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $15.80.

Sotera Health Price Performance

Shares of NASDAQ:SHC traded up $0.06 during trading on Monday, reaching $12.36. 3,458,511 shares of the company traded hands, compared to its average volume of 1,216,456. The company's 50 day moving average is $11.74 and its two-hundred day moving average is $12.55. The firm has a market capitalization of $3.51 billion, a PE ratio of 49.44 and a beta of 1.87. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. The firm had revenue of $254.52 million for the quarter, compared to analysts' expectations of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business's revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.13 earnings per share. As a group, sell-side analysts predict that Sotera Health will post 0.61 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.